Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
01099
01099
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
01099 News
UOB Kay Hian Supports ALI HEALTH and PA GOODDOCTOR as AI Innovations and National Policies Propel China's Internet Healthcare Industry
4d ago
aastocks
Sinopharm Accord, a Subsidiary of SINOPHARM, Projects Up to 90% Increase in Last Year's Net Profit
Jan 26 2026
aastocks
<Full-day Summary> HSI Falls 454 Points; HSTI Declines 111 Points; XPENG Drops More Than 10%; SHANGHAI IND H Reaches New Highs; Market Turnover Increases
Nov 18 2025
aastocks
<Daily Summary> HSI Ends at 26,696, Gaining 47 Points; HSTI Finishes at 5,924, Up 8 Points; XPENG Surges Over 17%; PING AN, XPENG, CHINA RES MIXC, HSBC HOLDINGS, ABC Reach New Peaks; Market Turnover Increases
Nov 11 2025
aastocks
Midday Update: HSI Ends at 26,595, Down 53 Points; HSTI at 5,900, Down 14 Points; XPENG Rises Over 15%; HSBC Holdings, AIA, CK Asset, ABC, and Poly Property Reach New Highs
Nov 11 2025
aastocks
HSBC Research Lowers Price Targets for SH PHARMA and SINOPHARM; Chinese Pharmaceutical Sector Lacks Short-Term Drivers
Nov 11 2025
aastocks
HSI Rises 267 Points at Midday; BABA-W and BIDU-SW Top Performers; WUXI APPTEC Jumps 6%
Oct 27 2025
aastocks
<Research> CLSA Views CN Biopharma Stock Decline as Attractive Buying Chance, Prefers CSPC PHARMA and SINOPHARM
Oct 27 2025
aastocks
HSI Drops 245 Points as Gold Jewelry Stocks Decline; LAOPU GOLD Falls 8%
Oct 22 2025
aastocks
<Daily Summary> HSI Ends at 25,781, Dropping 245 Points; HSTI Finishes at 5,923, Decreasing 84 Points; CHOW TAI FOOK Falls Over 5%; ABC and CHINA EAST AIR Reach New Peaks; Market Turnover Increases
Oct 22 2025
aastocks
SINOPHARM Surges Over 4% as Morgan Stanley Predicts Share Price Increase in the Coming Month
Oct 22 2025
aastocks
<Midday Update> HSI Declines by 329 Points; HSTI Falls by 127 Points; NTES Drops More Than 5%
Oct 22 2025
aastocks
<M Stanley Forecasts SINOPHARM Growth Over the Next 30 Days>
Oct 22 2025
aastocks
CLSA Increases Price Targets for SINOPHARM and SH PHARMA, Lowers CHINARES PHARMA's Target Price to HKD 5.6
Sep 15 2025
aastocks
BofAS Increases SINOPHARM (01099.HK) Price Target to $23, Maintains Buy Rating
Aug 26 2025
aastocks
Citi Lowers SINOPHARM (01099.HK) Price Target to $22.7, Maintains Buy Rating
Aug 26 2025
aastocks
Show More News
